NovaBridge Biosciences (NBP) Preferred Shares (2019 - 2020)
NovaBridge Biosciences (NBP) posted quarterly Preferred Shares of $1.3 billion for Q4 2020, up 592.0% year-over-year from $188.8 million in Q1 2020, and little changed quarter-over-quarter from $1.3 billion in Q2 2020.
Powered by 
Analysis
NovaBridge Biosciences (NBP) Preferred Shares (2019 - 2020) Analysis & Trends
NovaBridge Biosciences (NBP) has reported Preferred Shares for 2 consecutive years, with $1.3 billion the latest figure, recorded in Q4 2020.
- In Q4 2020, Preferred Shares rose 592.0% year-over-year to $1.3 billion; the TTM figure through Dec 2020 stood at $1.3 billion (up 592.0% YoY), while the FY2020 annual figure was $1.3 billion, up 592.0% from the prior year.
- Preferred Shares held at $1.3 billion in Q4 2020 per NBP's latest filing, from $1.3 billion in the prior quarter.
- Across five years, Preferred Shares topped out at $1.3 billion in Q2 2020 and bottomed at $188.8 million in Q4 2019.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Preferred Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | - |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | - |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | - |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | - |
| 10 | NovaBridge Biosciences | 197.68 Mn | 197.68 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2020 | 188.82 Mn |
| Jun 30, 2020 | 188.82 Mn |
| Dec 31, 2019 | 188.82 Mn |